We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Individual HPV Types Linked to HIV Infection

By LabMedica International staff writers
Posted on 15 Oct 2018
Although it is known that individuals living with human immunodeficiency virus (HIV) have a higher human papilloma virus (HPV) prevalence, the impact of individual HPV types on HIV acquisition is less clear.

Human papillomavirus (HPV) is the most prevalent sexually transmitted disease (STI) worldwide among all sexually active adults and affects approximately 50% of HIV-negative men who have sex with men (MSM), which may include transgender women (TW) because the groups are often erroneously combined.

An international team of scientists led by those at University of California, Riverside (Riverside, CA, USA) recruited for a cohort study 600 participants, both MSM and TW in Peru, to examine the relationship between anogenital warts and HIV acquisition. More...
Inclusion criteria were: born anatomically male, aged 18 to 40 years, HIV-negative, had anal intercourse with a male in the past 12 months, resident of metropolitan Lima, and willing to provide blood samples and anal swabs.

The team collected anogenital specimens at the baseline visit using pre-wetted Dacron swabs from the coronal sulcus or glans penis, penile shaft, anus, and scrotum, combined into one sample per participant, and stored at -80 °C. DNA was extracted using the QIAamp Media MDx Kit followed by polymerase chain reaction and HPV genotyping. Samples positive for β-globin or at least one HPV genotype were considered adequate and included in the analysis (overall β-globin positivity = 98%). The Roche Linear Array assay was used to detect 37 HPV genotypes.

The scientists reported that at baseline, 530 participants had HPV DNA present (61.1% with high-risk HPV, 84.9% with low-risk HPV). Among 571 participants who returned for any study visit, 73 (12.8%) became infected with HIV during the 2-year follow-up (6% HIV incidence). Compared to those without HIV, statistically significantly more participants with HIV had any HPV type present (97.3% versus 87.6%, respectively), more than one HPV type (79.5% versus 58.2%), or high-risk HPV (72.6% versus 51.4%). Some participants lost to follow-up could have been HIV-positive, which would have affected the relationship of HPV and HIV infection.

The authors concluded that their prospective study showed that participants with any HPV type, more than one HPV type, or high-risk HPV were more likely to test positive for HIV. Although most studies have shown HPV–HIV coinfection, their findings illustrate the strong relationship between individual HPV types and HIV infection. This further illustrates the potential utility of HPV vaccine for MSM and TW, not only for HPV prevention but also possibly for HIV prevention. The study was published on October 2, 2018, in the journal PLOS ONE.

Related Links:
University of California, Riverside


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.